Standout Papers

Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Even... 2014 2026 2018 2022 307
  1. Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531 (2014)
    Alan S. Gamis, Todd A. Alonzo et al. Journal of Clinical Oncology

Immediate Impact

62 standout
Sub-graph 1 of 22

Citing Papers

In-situ-sprayed therapeutic hydrogel for oxygen-actuated Janus regulation of postsurgical tumor recurrence/metastasis and wound healing
2024 Standout
The interaction of innate immune and adaptive immune system
2024 Standout
2 intermediate papers

Works of Laura Winter being referenced

Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
2014 Standout
Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia
2006

Author Peers

Author Last Decade Papers Cites
Laura Winter 303 167 126 167 20 526
Deborah McCue 318 117 171 193 14 563
Cara Angelotta 224 124 72 152 15 513
Heike Reinhardt 406 265 268 25 25 533
Éric Hermet 231 207 43 56 30 526
Mary Lynn Savoie 422 157 50 165 27 514
Diana Sun 64 85 121 55 32 569
Stephanie Stringer 184 68 228 41 19 549
Aiman Shalabi 29 265 56 94 17 508
Kathleen J. Beach 139 159 114 33 16 625
Kim Schmit-Pokorny 243 222 20 105 21 548

All Works

Loading papers...

Rankless by CCL
2026